ClinicalTrials.Veeva

Menu

Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease

F

Federal University of Bahia

Status and phase

Unknown
Phase 1

Conditions

Chronic Leg Ulcer
Sickle Cell Disease

Treatments

Biological: Infusion of Autologous Bone Marrow Mononuclear Cells

Study type

Interventional

Funder types

Other

Identifiers

NCT02619734
11738 (Registry Identifier)

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of autologous bone marrow stem cell implantation for the treatment of leg ulcer in adult patients with sickle cell disease.

Full description

Implantation of bone marrow mononuclear cells, including endothelial progenitor cells and mesenchymal stromal cells, into leg ulcers has been shown to improve wound healing.

In the present study the safety and efficacy of autologous bone marrow mononuclear cells implantation will be investigated in patients with chronic leg ulcers. Forty cases will be enrolled. Improvement in the pain, rate and extent of leg ulcer wound healing as measured by change in wound surface area will be evaluated until one year.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stable sickle cell disease patients
  • Patient hospitalized into the dermatology unit
  • Patient with an evolutive leg ulcer since more than 1 year
  • No infection at the time of surgery
  • Patient competent to give informed consent

Exclusion criteria

  • Patients with a history of corticosteroids or on active therapy
  • infection at the limb affected by ulcer
  • Recurrent painful crises,
  • Immunosuppressive drug therapy,
  • Pregnancy,
  • Presence of neoplastic disease or any other clinical concurrent condition other than sickle cell disease that predisposed them to the development of leg ulcer

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Control
No Intervention group
Description:
Conventional treatment established by the good clinical practice Patients received standard local care dressing method (compresses) to heal leg ulcers
Stem Cell Injection
Experimental group
Description:
Intramuscular implantation of Autologous bone marrow-derived mononuclear cells
Treatment:
Biological: Infusion of Autologous Bone Marrow Mononuclear Cells

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems